This trial is testing a new drug to see if it's safe and effective. It will be given to people with breast cancer who have failed other treatments.
8 Primary · 34 Secondary · Reporting Duration: Up to 24 months
Experimental Treatment
108 Total Participants · 11 Treatment Groups
Primary Treatment: PF-07248144 · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: